Position in ENGN
as of Mar 31, 2026
· filed Sep 22, 2026
Position Value
$612,900
-$199,800 QoQ
Shares Held
90,000
0.0% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Deeter Investments LLP holds $44,975,533 across 18 Biotechnology names. ENGN ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NKTR |
Nektar Therapeutics
|
239,300 | $17,217,635 | |
| 2 | CYTK |
Cytokinetics Inc
|
92,739 | $6,112,427 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
50,000 | $3,713,000 | |
| 4 | ALMS |
Alumis Inc.
|
157,022 | $3,459,194 | |
| 5 | PRTA |
Prothena Corp Public Ltd Co
|
300,000 | $2,916,000 | |
| 6 | LSTA |
Lisata Therapeutics, Inc.
|
364,479 | $1,826,039 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
75,567 | $1,644,337 | |
| 8 | TENX |
Tenax Therapeutics, Inc.
|
100,000 | $1,599,000 |
All Filings in ENGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $612,900 | 90,000 | Shares | Sole | 2026-09-22 | |
| 2025-12-31 | $812,700 | 90,000 | Shares | Sole | 2026-08-28 | |
| No filing history on record for this holder in this stock. | ||||||